LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

#EFIB2022:  Industrial biotechnology community comes together in Vilnius next week

19/10/2022
PRESS RELEASE

PRESS RELEASE

Brussels, 19 October 2022 

Leading industry leaders, SMEs representatives, start-ups, policy makers and academia are expected in Vilnius on 26-27 October, 2022 to join the 15th European Forum for Industrial Biotechnology and the Bioeconomy (EFIB). The annual event, hosted by EuropaBio, welcomes almost 300 participants to join discussions around next generation economies and how industrial biotechnology can contribute to a more sustainable society.

This year’s agenda amongst almost 60 speakers who will join the Conference in person and online, will feature Thierry Breton, European Commissioner for Internal Market, Virginijus Sinkevičius, European Commissioner for Environment, Oceans and Fisheries, prof. Virginijus Šikšnys, Vilnius university, and representatives from companies such as Solvay, DSM, LanzaTech, Ev Biotech and others.

‘EuropaBio is delighted to be hosting this year’s forum in Vilnius, with delegates joining us from across Europe. The theme ‘Next generation economies: Industrial biotechnology for a sustainable society comes at a critical time for Europe, as we experience a generational point of transition. Now is the time for the bioeconomy to achieve its full potential, driven by Europe’s powerful science base, inspirational SMEs, long term strategies in global companies and changes in consumer demand.’, says Dr Claire Skentelbery, Director General of EuropaBio.

EFIB participants will also have the chance to meet with 14 local and international start-ups, learn about recent projects in the industrial biotechnology field at the dedicated poster presentation area and set up business meetings via EFIB Partnering tool. EuropaBio’s Executive Roundtable will bring together members and invited guests for a discussion on key recommendations to deliver a competitive bioeconomy, developed for the EFIB Vilnius Statement.

#EFIB2022: Industrial biotechnology community comes together in Vilnius next week


Download
Share
Communications Team
Communications Team

Related posts

14/07/2025

EuropaBio Annual Report 2025


Read more
11/07/2025

Industrial Decarbonisation Accelerator Act – EuropaBio Position


Read more
03/07/2025

Life Sciences Strategy Embraces Biotech for Global Impact


Read more

Important links

  • Public Consultation Response to the European Commission’s 28th Regime proposal
  • EuropaBio Annual Report 2025

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.